The Role of Hormone Therapy in Prostate Cancer

Abstract

Brachytherapy allows most patients to maintain potency and reduces the risk of urinary incontinence. But, again, there are a number of nuances that prevent brachytherapy from becoming the "gold standard", among which:

the inability to correctly stage the tumor process and determine the radicality of the treatment (there is no sample taken from the prostate and lymph nodes);

the method is suitable only for patients with a minimal degree of tumor process (not even for all cases of local prostate cancer);

prostate size restrictions - the procedure is not suitable for patients with severe urinary disorders (difficulty urinating, slow urine flow, frequent urination, strong urges, repeated nighttime trips to the toilet, onset of urinary incontinence, etc.);

The postoperative period is often complicated by problems such as acute urinary retention, which requires additional therapeutic measures.